Literature DB >> 10831231

Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands?

C Chen1.   

Abstract

1. Growth hormone (GH) secretion is thought to occur under the reciprocal regulation of two hypothalamic hormones, namely GH-releasing hormone (GHRH) and somatostatin (SRIF), through their engagement with specific cell-surface receptors on the anterior pituitary somatotropes. 2. In addition to GHRH and SRIF, synthetic GH-releasing peptides (GHRP) or GH secretagogue(s) (GHS) regulate GH release through the activation of a novel receptor, the GHS receptor (GHS-R). 3. The cloning of the GHS-R from human, swine and rat identifies a novel G-protein-coupled receptor involved in the control of GH secretion and supports the existence of an undiscovered hormone that may activate this receptor. 4. Varieties of intracellular signalling systems are suggested to mediate the action of GHS, which include changes in intracellular free Ca2+ ([Ca2+]i), cAMP, protein kinases A and C, phospholipase C etc. 5. With regard to the use of signalling systems by GHS, especially a new form of GHRP or GHRP-2, a clear species difference has been demonstrated, supporting the possibility of more than one type of GHS-R.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831231     DOI: 10.1046/j.1440-1681.2000.03258.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  11 in total

1.  Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway.

Authors:  Delphine Mousseaux; Lionel Le Gallic; Joanne Ryan; Catherine Oiry; Didier Gagne; Jean-Alain Fehrentz; Jean-Claude Galleyrand; Jean Martinez
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

2.  Effects of genistein on stereological and hormonal characteristics of the pituitary somatotrophs in rats.

Authors:  Svetlana Trifunović; Milica Manojlović-Stojanoski; Vladimir Ajdžanović; Nataša Nestorović; Nataša Ristić; Ivana Medigović; Verica Milošević
Journal:  Endocrine       Date:  2014-04-22       Impact factor: 3.633

3.  Growth hormone-releasing peptide-2 reduces inward rectifying K+ currents via a PKA-cAMP-mediated signalling pathway in ovine somatotropes.

Authors:  Ruwei Xu; Yufeng Zhao; Chen Chen
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

4.  Daily low-dose administration of growth hormone secretagogue stimulates pulsatile growth hormone secretion and elevates plasma insulin-like growth factor-1 levels in pigs.

Authors:  K Malmlöf; M K Bauer; P B Johansen; M Ankersen; J D Veldhuis
Journal:  Endocrine       Date:  2001-12       Impact factor: 3.633

5.  Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake.

Authors:  Blandine Laferrère; Allison B Hart; Cyril Y Bowers
Journal:  Obesity (Silver Spring)       Date:  2006-06       Impact factor: 5.002

6.  Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.

Authors:  Blandine Laferrère; Cynthia Abraham; Colleen D Russell; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2005-02       Impact factor: 5.958

7.  Up-regulation of high voltage-activated Ca(2+) channels in GC somatotropes after long-term exposure to ghrelin and growth hormone releasing peptide-6.

Authors:  Belisario Dominguez; Traudy Avila; Jorge Flores-Hernandez; Gustavo Lopez-Lopez; Herminia Martinez-Rodriguez; Ricardo Felix; Eduardo Monjaraz
Journal:  Cell Mol Neurobiol       Date:  2008-02-08       Impact factor: 5.046

8.  Upregulation of voltage-gated calcium channel cav1.3 in bovine somatotropes treated with ghrelin.

Authors:  V M Salinas Zarate; A Magdaleno Méndez; B Domínguez Mancera; A Rodríguez Andrade; M Barrientos Morales; P Cervantes Acosta; A Hernández Beltrán; D Romero Salas; J L V Flores Hernández; E Monjaraz Guzmán; D R Félix Grijalva
Journal:  J Signal Transduct       Date:  2013-12-18

9.  Potassium Current Is Not Affected by Long-Term Exposure to Ghrelin or GHRP-6 in Somatotropes GC Cells.

Authors:  Belisario Domínguez Mancera; Eduardo Monjaraz Guzman; Jorge L V Flores-Hernández; Manuel Barrientos Morales; José M Martínez Hernandez; Antonio Hernández Beltran; Patricia Cervantes Acosta
Journal:  J Biophys       Date:  2013-02-24

Review 10.  Targeting the ghrelin receptor: orally active GHS and cortistatin analogs.

Authors:  Romano Deghenghi; Fabio Broglio; Mauro Papotti; Giampiero Muccioli; Ezio Ghigo
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.